Samsung Bioepis has received Brazilian Ministry of Health approval for Brenzys, an Enbrel biosimilar product. In Brazil, 90%+ of autoimmune disease treatments (e.g. Enbrel, Humira & Remicade) are available via the nation’s productive development partnership (PDP)...